David H. Crean's most recent trade in Histogen Inc was a trade of 6,835 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Histogen Inc | David H. Crean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 6,835 | 6,835 | - | - | Stock Option (right to buy) | |
| Histogen Inc | David H. Crean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Histogen Inc | David H. Crean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Histogen Inc | David H. Crean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |